EIT Health is a consortium of more than 50 core partners and 90 associate partners from leading businesses, research centres and universities from across 14 EU countries. EIT Health was designated as an EIT Knowledge and Innovation Community (KIC) by the EIT Governing Board on 09 December 2014.
The goal of EIT Health is to contribute to increasing the competitiveness of European industry, improve the quality of life of Europe’s citizens and the sustainability of healthcare system.
The partnership will promote entrepreneurship and develop innovations in healthy living and active ageing, providing Europe with new opportunities and resources. This will be achieved through delivering products, concepts and services, including educational programmes that will nurture talents and train the workforce of tomorrow.
EIT Health will overcome the fragmentation of different healthcare systems in Europe and give companies easier access to markets across the EU. The critical mass of partners from business and industry, education, research, healthcare providers and insurance companies within EIT Health, opens the path to reduced time-to-market for added-value products and services.
EIT Health outreach activities are expected to spread all over Europe – establishing new ties to expand innovation and growth.
and the URL is eithealth.eu
BIO Clustermanagement NRW GmbH is representing BIO.NRW Cluster Biotechnology North Rhine-Westphalia (NRW) as founding associate member within EIT Health. The company offers a variety of services and promotes biotechnology from NRW.
BIO.NRW had started in 2010 to implement a private equity community in the federal German state North Rhine-Westphalia (about 18 Mio inhabitants). Through organizing regular meetings with private investors and financial institutions, start-ups and founders are enabled to “get going” by receiving financial support for their respective enterprises.
BIO.NRW offers a format that brings start-up companies or projects into close contact with private investors, business angels and financing institutions (i.e. state development banks, venture capital fonds including corporate venture) from across the EU.
Also, as a case in point, with Qithera GmbH a company in the field of new cancer therapies has been founded together with business angels as major shareholders and BIO Clustermanagement NRW GmbH as a minority shareholder. The strong presence of surrounding (global) pharmaceutical and chemical enterprises and successful “start-ups of the past” like Qiagen and Miltenyi Biotec, proves the fact that the possibilities for business development in the region were and are ideal.
DWF is a leading legal business with an award-winning reputation for client service excellence and effective operational management. Named by the Financial Times as one of Europe’s most innovative law firms, DWF has been named in the top five for most recommended lawyers in the UK, by this year’s Legal 500 UK.
Employing over 2,300 people across the UK and Ireland, Germany, Dubai and Brussels, DWF is a full service firm with core strengths in corporate & banking, insurance and litigation, and in-depth industry expertise in several chosen sectors including central & local government; energy & industrials; financial services; real estate; retail, food & hospitality; technology; and transport.
The success of the DWF strategy is based on:
· Understanding our clients
· Engaging with our people
· Doing things differently
This enables us to add more value and to deliver legal solutions that enable our clients to excel.
It’s not just what we deliver; it’s how we do it. Our innovative culture is hard-wired into our business objectives, and we engage with and listen to all our people to ensure that they are working proactively together to create an outstanding client experience. DWF is more than a just a law firm - we are a legal business.
BIO Clustermanagement NRW GmbH
Merowingerplatz 1 40225 Duesseldorf, Germany
Registered as a GmbH in Duesseldorf Reg. No. HRB 65649, VAT ID: DE279873727